MedTrace Logo

ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered

NCT02264730 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-10-15

No results posted yet for this study

Summary

Phase 1 Single-Arm Study Evaluating ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery in Which Liver Bleeding is Encountered.

Conditions

Interventions

DRUG

ClotFoam

Patient has not received blood products between screenings

Sponsors & Collaborators

  • Washington University School of Medicine

    collaborator OTHER

  • Biomedica Management Corporation

    lead INDUSTRY

Principal Investigators

  • Grant Bochicchio, MD, MPH FACS · Washington University School of Medicine Barnes Jewish Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264730 on ClinicalTrials.gov